RA Capital Management - POINT BIOPHARMA GLOBAL INC ownership

POINT BIOPHARMA GLOBAL INC's ticker is PNT and the CUSIP is 730541109. A total of 84 filers reported holding POINT BIOPHARMA GLOBAL INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
RA Capital Management ownership history of POINT BIOPHARMA GLOBAL INC
ValueSharesWeighting
Q2 2022$61,311,000
-14.6%
9,003,0180.0%1.64%
+4.4%
Q1 2022$71,754,000
+42.3%
9,003,0180.0%1.57%
+76.2%
Q4 2021$50,417,000
-26.0%
9,003,018
+1.7%
0.89%
-5.8%
Q3 2021$68,103,0008,856,0180.94%
Other shareholders
POINT BIOPHARMA GLOBAL INC shareholders Q2 2022
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 2,909,960$19,409,4333.54%
JOHNSON & JOHNSON 1,000,000$6,670,0002.46%
BVF INC/IL 10,563,748$70,460,1991.90%
SPHERA FUNDS MANAGEMENT LTD. 952,642$6,354,1221.16%
Boxer Capital, LLC 2,500,000$16,675,0000.89%
Pier Capital, LLC 732,936$4,888,6830.79%
Deep Track Capital, LP 2,781,565$18,553,0390.72%
PFM Health Sciences, LP 1,613,516$10,762,1520.51%
Eagle Health Investments LP 306,142$2,041,9670.45%
Onex Canada Asset Management Inc. 772,905$5,155,2760.40%
View complete list of POINT BIOPHARMA GLOBAL INC shareholders